CClinicalTrials.gg
CompletedNCT05437354OncoSurveyUpdated Oct 4, 2022

Online Survey: Oncologists' Thoughts Regarding Their Patients

An observational study in Oncology, sponsored by Cairo University. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2022-10-04.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
500
Sex
All
01

Study summary

Our study is a questionnaire targeting the medical staff in Oncology. It aims at exploring the thoughts and expectations of the medical staff in Oncology regarding their patients management and prognosis worldwide. It also investigates the factors that affect these thoughts and expectations and their effects.

Read the detailed description

Oncology patients need to trust the medical staff dealing with them. They are expecting knowledge, well communication, competence .. etc. This Questionnaire is for research purpose aiming at exploring the thoughts and expectations of the medical staff in Oncology regarding their patients management and prognosis worldwide. It investigates the factors that affect these thoughts and expectations and their effects. The results of this survey will shed the light on the oncologists' side of their relationship with their patients, which is often ignored or down played.

02

Conditions studied

  • Oncology

Browse trials for

Keywords

  • Oncologists, Survey, Expectations
03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 500 is above the median of 204 across 1,683 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Any Medical staff in Oncology Field worldwide, with no age limit

Inclusion criteria

  1. Medical/Clinical/Radiation Oncology Physicians
  2. Surgical Oncology Physicians
  3. Oncology nurses

Exclusion criteria

Exclusion Criteria:

  • Medical staff not related to oncology field
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
500 participants (actual)
Patient registry
No

Interventions

  • Othersurvey

    Oncology medical staff should respond to a survey

06

What researchers measure

Primary outcomes

  1. What are the most and least important factors the oncologists usually consider when they build their management plan?

    We would like to know the factors that the oncologists usually consider for a patient's management plan. This will be done via a questionnaire.

    Time frame: Two months

Secondary outcomes

  1. How often do oncologists inform patients of the detailed management plan? and Why?

    We would like to know if the oncologists inform the patients the detailed management plan. and if they are expecting patients to fully understand the plan. This will be done via a questionnaire.

    Time frame: Two months

  2. How satisfied do oncologists think most patients are during their management.

    we would like to know how satisfied are the patients during their management, and why they are unsatisfied from the oncologists point of view. This will be done via a questionnaire.

    Time frame: Two months

  3. How often are Oncology patients open to their case being discussed in multidisciplinary clinics or being referred to psychiatrists/Nutritionists/palliative care/hospice?

    This will be done via a questionnaire to see their point of view.

    Time frame: Two months

07

Study locations

1 site
  • Cairo University
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided — The questionnaire is aiming at exploring the thoughts and expectations of the medical staff in Oncology regarding their patients management and prognosis worldwide. It would be published after its completeion

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05437354
Lead sponsor
Cairo University
Responsible party
Riham H. AbdelAziz (Clinical Oncology Lecturer and consultant, Cairo University) — Principal investigator
First posted
Jun 29, 2022
Start date
Jun 20, 2022
Primary completion
Oct 1, 2022
Completion
Oct 1, 2022
Last update
Oct 4, 2022

Study contacts

Riham AbdelAziz, MD/PhD
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion